Key Segmentation
By Technique
-
Fluorescence In Situ Hybridization (FISH)
-
Chromogenic In Situ Hybridization (CISH)
-
RNA-Scope / Amplified RNA-ISH
-
Single Molecule FISH
-
Others
By Probe Type
-
DNA Probes
-
RNA Probes
By Application
-
Cancer Diagnostics & Research
-
Genetic & Chromosomal Disorders
-
Infectious Diseases
-
Neuroscience & Developmental Biology
-
Others
By End User
-
Research Institutes & Academic Centers
-
Hospitals & Diagnostic Laboratories
-
Pharmaceutical & Biotechnology Companies
-
Contract Research Organizations
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
The In Situ Hybridization Market is expected to grow at a CAGR of 7.33% from 2026 to 2035.
The In Situ Hybridization Market was valued at USD 2.10 Billion in 2025.
Growing prevalence of cancer requiring companion diagnostic ISH testing for targeted therapy patient selection.
FISH dominated the In Situ Hybridization Market with 54.25% share in 2025.
North America dominated the In Situ Hybridization Market in 2025.